|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0033572,
umls-concept:C0138741,
umls-concept:C0205210,
umls-concept:C0205474,
umls-concept:C0441889,
umls-concept:C1274040,
umls-concept:C1366489,
umls-concept:C1417779,
umls-concept:C1442488,
umls-concept:C1514695
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2011-5-9
|
|
pubmed:abstractText |
To assess ultrahigh (UH; prostate-specific antigen [PSA] levels ?50 ng/ml) patient outcomes by comparison to other high-risk patient outcomes and to identify outcome predictors.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1879-355X
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright © 2011 Elsevier Inc. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
80
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
445-52
|
|
pubmed:meshHeading |
pubmed-meshheading:20615632-Aged,
pubmed-meshheading:20615632-Aged, 80 and over,
pubmed-meshheading:20615632-Androgen Antagonists,
pubmed-meshheading:20615632-Humans,
pubmed-meshheading:20615632-Karnofsky Performance Status,
pubmed-meshheading:20615632-Male,
pubmed-meshheading:20615632-Middle Aged,
pubmed-meshheading:20615632-Neoplasm Staging,
pubmed-meshheading:20615632-Prostate-Specific Antigen,
pubmed-meshheading:20615632-Prostatic Neoplasms,
pubmed-meshheading:20615632-Regression Analysis,
pubmed-meshheading:20615632-Survival Analysis,
pubmed-meshheading:20615632-Treatment Outcome
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Impact of ultrahigh baseline PSA levels on biochemical and clinical outcomes in two Radiation Therapy Oncology Group prostate clinical trials.
|
|
pubmed:affiliation |
Department of Oncology, University of Western Ontario, London, Ontario, Canada. george.rodrigues@lhsc.on.ca
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Clinical Trial, Phase III,
Research Support, N.I.H., Extramural
|
